Company
Clarity Pharmaceutical
Also known as Clarity Pharmaceuticals
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products for oncology, based on its proprietary SAR Technology platform. Its Targeted Copper Theranostic (TCT) platform utilises the pairing of copper-64 for imaging and copper-67 for therapy, delivering accuracy and precision in the treatment of a range of cancers. The clinical development pipeline includes SAR-bisPSMA, SAR-Bombesin, and SARTATE, targeting prostate cancer, breast cancer, neuroendocrine tumours, and neuroblastoma.
Loading relationship preview